Trilaciclib is a first-of-its-kind prescription medicine that protects against the damage caused to bone marrow cells during chemotherapy. Since bone marrow cells form red and white blood cells, trilaciclib helps patients undergoing chemotherapy by reducing the side effects that
...
Small cell lung cancer (SCLC) is a rare and aggressive form of lung cancer. Several factors make it challenging to treat with long-term success. Screening is uncommon. The cancer is often in an advanced stage by the time it
...
Small cell lung cancer life expectancy and the need for more research Lung cancer research has made many wonderful advances in just the past few years. However, small cell lung cancer life expectancy has not increased as quickly as
...
28-Year-Old Faces Small Cell Lung Cancer Diagnosis Back in 2006, special education teacher Montessa Lee didn’t think too much about the intermittent pain she was experiencing in her chest. It wasn’t until her cousin insisted, in fact, that she
...
Lung cancer is a group of diseases defined by what type of lung tissue the abnormal cells originated in. This is known as the “histology” of the cells. There are 2 main types of lung cancer. Understanding the differences
...
Vanderbilt University Christine Lovly, MD, PhD, assistant professor of Medicine, has received a $200,000 grant to support promising new research on lung cancer. The Lung Cancer Foundation of America (LCFA) and the International Association for the Study of Lung…
Lung cancer is the number one cancer killer worldwide. Of the 220,000 new cases diagnosed each year, Small Cell Lung Cancer (SCLC) accounts for 15% of cases. As an aggressive form of lung cancer, better therapies are needed desperately.
...
Funding supports search for new treatments for the deadliest form of cancer LOS ANGELES, Feb. 7, 2018 /PRNewswire/ – Groundbreaking research into the early diagnosis of lung cancer and potential new treatments have been awarded funding through two lung…